In addition, the IDH1.R132H, GNAS.R201C, and EGFR.T790M mutations in Glioma, EGC, and NSCLC were the most significantly different point mutations (p = 0.00021, 0.00027 and 0.0011, respectively). Here, EGFR is linked to non-small cell lung carcinoma.